Funding Rounds
IntraBio

IntraBio Series A (2018, $10M)

IntraBio

New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $10.30M